Vor Bio is a biotech company advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor.
Join Vor in tackling autoimmune disease at its root by advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor. The Medical Science Liaison (MSL) in Rheumatology will foster partnerships with healthcare professionals, clinical researchers, and advocacy groups in relevant disorders.
Vor Bio is a biotech company advancing telitacicept, a first- and potentially best-in-class dual BAFF/APRIL inhibitor.
Vor Bio